Increased nuclear β-catenin accumulation is observed more frequently in primary human triple negative breast cancers [94,95], whereas ER+ breast cancers exhibit an RNA profile consistent with enhanced Wnt/β-catenin signaling [96]. The gene discussed is ESR1; the disease is breast cancer.